Outside Counsel Can Be the Right Choice, but Know When
January 9, 2019 | Rivkin Rounds Staff | Employer/Employee | Hospitals | Litigation
An article in Relias Media’s Healthcare Risk Management, “Outside Counsel Can Be the Right Choice, but Know When,” discussed when and why it might be appropriate for healthcare organizations to use outside counsel. Rivkin Radler’s Jeffrey Rust was quoted extensively in the article. Jeff noted that it is especially important to retain outside counsel in …
Read More
OB/GYN Practice Liable to Patient for Breach of Confidentiality
January 7, 2019 | Eric D. Fader | HIPAA | Legislation and Public Policy | Litigation
A Connecticut state court ruled in December that an obstetrics and gynecology practice must pay a former patient close to $2 million, the latest round in an 11-year saga in which the case was appealed to the state Supreme Court twice. The defendant medical practice was found to have breached the confidentiality of the plaintiff’s …
Read More
The False Claims Act: A Powerful Tool Against Federal Health Care Program Fraud
January 7, 2019 | Rivkin Rounds Staff | False Claims Act | Fraud and Abuse | Litigation | Medical Devices | Medicare and Medicaid | Pharmaceuticals
Evan Krinick authored an article, “The False Claims Act: A Powerful Tool Against Federal Health Care Program Fraud,” that was published in the New York Law Journal.  The article discusses recent actions taken by U.S. Attorneys in New York against health care providers under the FCA. …
Read More
Diabetes Pill Marketers Settle FTC Complaint
December 14, 2018 | Steven Shapiro | Fraud and Abuse | Litigation | Pharmaceuticals
On December 4, the Federal Trade Commission (FTC) announced the settlement of a complaint against Nobetes Corporation, which marketed and sold a pill that supposedly treats diabetes. The FTC complaint had alleged that the company made false or unsubstantiated health claims, engaged in illegal billing practices, and used deceptive endorsements in the marketing and sale …
Read More
DOJ Files Amicus Brief Declaring Intention to Dismiss FCA Case
December 12, 2018 | Geoffrey R. Kaiser | False Claims Act | Fraud and Abuse | Legislation and Public Policy | Litigation | Pharmaceuticals
On November 30, the U.S. Department of Justice (DOJ) filed an amicus curiae brief urging the U.S. Supreme Court to deny a petition for a writ of certiorari filed by Gilead Sciences, Inc. from a Ninth Circuit Court of Appeals decision which had revived a declined False Claims Act (FCA) lawsuit brought by two former …
Read More
DOJ Revisits the Yates Memo
December 5, 2018 | Geoffrey R. Kaiser | Fraud and Abuse | Legislation and Public Policy | Litigation
In remarks delivered on November 29 at the American Conference Institute’s 35th International Conference on the Foreign Corrupt Practices Act, Deputy Attorney General Rod J. Rosenstein announced that the U.S. Department of Justice (DOJ) had revised its policy concerning individual accountability in corporate cases. That policy, previously set forth in a September 2015 memorandum issued by …
Read More
Think HIPAA When Talking to Reporters: A Case Example
December 3, 2018 | Cassandra Rivais | Carol A. Hyde | HIPAA | Litigation
Allergy Associates of Hartford, P.C. has agreed to pay $125,000 to the Office for Civil Rights as a settlement for HIPAA violations. The physician practice has also agreed to implement a two-year corrective action plan to monitor its HIPAA compliance. The Resolution Agreement is available on the U.S. Department of Health & Human Services’ website. …
Read More
Allergy Practice Discloses Patient Info to Reporter, Pays $125,000
November 27, 2018 | Rivkin Rounds Staff | HIPAA | Litigation
An article in Bloomberg Law’s Health Law & Business, “Allergy Practice Discloses Patient Info to Reporter, Pays $125,000,” discussed a recent HIPAA settlement arising out of a physician’s disclosure of a patient’s protected health information (PHI) to a television reporter. Rivkin Radler’s Eric Fader was quoted in the article. The settlement was announced on November 26 …
Read More
Dental Clinics are First on OIG’s “High Risk” List
November 16, 2018 | Margarita Christoforou | Fraud and Abuse | Litigation | Medicare and Medicaid
Two dental care companies are the first entities to be placed on the new High Risk – Heightened Scrutiny list created by the U.S. Department of Health and Human Services’ Office of Inspector General (OIG) for providers that pose a significant risk to federal healthcare programs and beneficiaries.  Each of the companies settled with the …
Read More
HHS Ordered to Eliminate Medicare Appeals Backlog
November 7, 2018 | Cassandra Rivais | Hospitals | Litigation | Medicare and Medicaid
Healthcare facilities waiting to hear back on Medicare appeals received good news on November 1, when the U.S. District Court for the District of Columbia ordered the U.S. Department of Health and Human Services (HHS) to eliminate its backlog of 426,594 Medicare appeals by 2022. The order, in American Hospital Association, et al., v. Azar, …
Read More

show more

Get legal updates and news delivered to your inbox